Cell Reports (Apr 2019)

Uncovering the Role of N-Acetyl-Aspartyl-Glutamate as a Glutamate Reservoir in Cancer

  • Tu Nguyen,
  • Brian James Kirsch,
  • Ryoichi Asaka,
  • Karim Nabi,
  • Addison Quinones,
  • Jessica Tan,
  • Marjorie Justine Antonio,
  • Felipe Camelo,
  • Ting Li,
  • Stephanie Nguyen,
  • Giang Hoang,
  • Kiet Nguyen,
  • Sunag Udupa,
  • Christos Sazeides,
  • Yao-An Shen,
  • Amira Elgogary,
  • Juvenal Reyes,
  • Liang Zhao,
  • Andre Kleensang,
  • Kaisorn Lee Chaichana,
  • Thomas Hartung,
  • Michael J. Betenbaugh,
  • Suely K. Marie,
  • Jin G. Jung,
  • Tian-Li Wang,
  • Edward Gabrielson,
  • Anne Le

Journal volume & issue
Vol. 27, no. 2
pp. 491 – 501.e6

Abstract

Read online

Summary: N-acetyl-aspartyl-glutamate (NAAG) is a peptide-based neurotransmitter that has been extensively studied in many neurological diseases. In this study, we show a specific role of NAAG in cancer. We found that NAAG is more abundant in higher grade cancers and is a source of glutamate in cancers expressing glutamate carboxypeptidase II (GCPII), the enzyme that hydrolyzes NAAG to glutamate and N-acetyl-aspartate (NAA). Knocking down GCPII expression through genetic alteration or pharmacological inhibition of GCPII results in a reduction of both glutamate concentrations and cancer growth. Moreover, targeting GCPII in combination with glutaminase inhibition accentuates these effects. These findings suggest that NAAG serves as an important reservoir to provide glutamate to cancer cells through GCPII when glutamate production from other sources is limited. Thus, GCPII is a viable target for cancer therapy, either alone or in combination with glutaminase inhibition. : Nguyen et al. show that NAAG is more abundant in higher grade cancers and a source of glutamate in cancers expressing GCPII, the enzyme that hydrolyzes NAAG to glutamate and NAA. The results suggest that GCPII is a viable target for cancer therapy, either alone or in combination with glutaminase inhibition. Keywords: N-acetyl-aspartyl-glutamate, NAAG, glutamate carboxypeptidase II, GCPII, glutaminase inhibitor, glutamate deprivation, glutamate reservoir, stable isotope resolved, metabolomics